Intellia director granted shares and options
Intellia Therapeutics, Inc. director Jesse Goodman reported equity awards consisting of common stock and stock options as part of compensation.
Rhea-AI Filing Summary
Intellia Therapeutics, Inc. director Jesse Goodman reported equity awards consisting of common stock and stock options as part of compensation. He received 9,200 shares of Common Stock$0.00 per share33,559 shares
Goodman also received a stock option for 13,300 shares of Common Stock$12.89 per share13,300 shares
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 22,500 shares
Grant/Award
2 txns
Insider
GOODMAN JESSE
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 13,300 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 9,200 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 13,300 contracts (Direct);
Common Stock — 33,559 shares (Direct)
Footnotes (2)
- F1. Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.
- F2. This option was granted on June 9, 2026 with respect to 13,300 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant.
Key Figures
Common stock granted: 9,200 shares
Option grant size: 13,300 shares
Option exercise price: $12.89 per share
+2 more
5 metrics
Common stock granted
9,200 shares
Award of Common Stock at $0.00 per share on June 9, 2026
Option grant size
13,300 shares
Stock Option (right to buy) granted June 9, 2026
Option exercise price
$12.89 per share
Exercise price for 13,300-share stock option
Common shares held after
33,559 shares
Total direct common stock holdings after awards
Option expiration
June 8, 2036
Expiration date of stock option covering 13,300 shares
Key Terms
restricted stock units, Stock Option (right to buy), exercise price, annual meeting of stockholders, +1 more
5 terms
restricted stock units financial
"Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option (right to buy) financial
"Stock Option (right to buy) with respect to 13,300 shares of Common Stock"
exercise price financial
"conversion_or_exercise_price: "12.8900" for the stock option grant"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
annual meeting of stockholders financial
"vests in full on the earlier to occur of the first anniversary or the date of the next annual meeting of stockholders"
expiration date financial
"expiration_date: "2036-06-08T00:00:00.000Z" for the stock option"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Intellia Therapeutics (NTLA) director Jesse Goodman report on this Form 4?
Jesse Goodman reported equity awards consisting of common stock and stock options. He received shares at no cost via restricted stock units and a new stock option grant, increasing both his direct share ownership and his derivative exposure to Intellia Therapeutics stock.
What stock options did Jesse Goodman receive from Intellia Therapeutics (NTLA)?
He received a stock option covering 13,300 shares of Intellia common stock at an exercise price of $12.89 per share. The option represents a right to buy shares in the future, subject to the vesting schedule disclosed in the filing footnotes.
When do Jesse Goodman’s new Intellia Therapeutics (NTLA) stock options vest?
The options vest in full on the earlier of the first anniversary of the June 9, 2026 grant date or the date of the next annual meeting of stockholders. This single-vesting date structure provides Goodman with potential future ownership once the condition is met.
Are Jesse Goodman’s Intellia Therapeutics (NTLA) transactions open-market buys or compensation awards?
These transactions are compensation-related awards, not open-market purchases or sales. The Form 4 lists them under code "A" for grants or awards, covering both restricted stock units converted into shares and a new stock option grant with a specified exercise price.
AI-generated analysis. How Rhea-AI works. Not financial advice.
